Clear Harbor Asset Management’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $246K | Hold |
79,761
| – | – | 0.02% | 355 |
|
|
2025
Q1 | $278K | Hold |
79,761
| – | – | 0.02% | 329 |
|
|
2024
Q4 | $261K | Buy |
79,761
+5,000
| +7% | +$16.4K | 0.02% | 318 |
|
|
2024
Q3 | $288K | Sell |
74,761
-26,000
| -26% | -$100K | 0.02% | 293 |
|
|
2024
Q2 | $311K | Sell |
100,761
-15,500
| -13% | -$47.9K | 0.03% | 280 |
|
|
2024
Q1 | $300K | Sell |
116,261
-23,000
| -17% | -$59.3K | 0.03% | 283 |
|
|
2023
Q4 | $348K | Buy |
139,261
+7,500
| +6% | +$18.8K | 0.03% | 251 |
|
|
2023
Q3 | $267K | Buy |
131,761
+78,761
| +149% | +$160K | 0.03% | 270 |
|
|
2023
Q2 | $122K | Hold |
53,000
| – | – | 0.01% | 320 |
|
|
2023
Q1 | $161K | Hold |
53,000
| – | – | 0.02% | 340 |
|
|
2022
Q4 | $123K | Buy |
+53,000
| New | +$123K | 0.02% | 329 |
|